Sharkey, Howes & Javer Pfizer Inc Transaction History

Sharkey, Howes & Javer

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$46.53 - $55.17 $225,019 - $266,802	4,836 New	4,836 $254,000
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $73,654 - $95,508	-2,267 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$36.98 - $41.52 $13,238 - $14,864	358 Added 18.75%	2,267 $98,000
Q1 2018 Apr 26, 2018	BUY	$31.91 - $37.02 $21,379 - $24,803	670 Added 54.08%	1,909 $67,000
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $37,883 - $40,195	1,139 Added 1139.0%	1,239 $45,000
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $37,883 - $40,195	-1,139 Reduced 91.93%	100 $11,000
Q3 2017 Oct 11, 2017	BUY	$31.0 - $34.15 $38,409 - $42,311	1,239	1,239 $45,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Sharkey, Howes & Javer, based on Form 13F filings with the SEC.

Stay updated on Sharkey, Howes & Javer with notifications on news.